Used as an intermediate in the synthesis of certain pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its structure supports peptide mimetic design, making it valuable in medicinal chemistry for creating drugs with improved metabolic stability and binding affinity. Commonly employed in solid-phase peptide synthesis where the tert-butyloxycarbonyl (Boc) protecting group ensures selective amine protection. The allyl-protected phenolic moiety allows for orthogonal deprotection strategies, enabling precise control during multi-step syntheses. Widely applied in research settings for developing enzyme inhibitors and targeted therapeutics.